Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vitec Software Group AB: Bulletin from AGM 2016

AGM of Vitec Software Group AB (publ) was held on May 11 2016 in Umeå. DividendThe proposed dividend of 90 cents per share was approved by the AGM. The record date for the dividend is Friday, May 13 2016. Payment from Euroclear Sweden AB is expected Wednesday, May 18th, 2016. Adoption of income statement and balance sheetThe AGM adopted the income statement and balance sheet for the Parent Company and the consolidated income statement and consolidated balance sheet for 2015. DischargeBoard members and the President were discharged from liability for the financial year 2015.

Selvaag Bolig ASA: Q1 2016: Invitation to presentation of first quarter 2016 results

Selvaag Bolig ASA will publish its first quarter 2016 results on Thursday 19 May at 07:00 am CET. The quarterly report and the presentation materials will be available on the company's website, www.selvaagboligasa.no/en and www.newsweb.no, as well as news wires. CEO Baard Schumann and CFO Sverre Molvik will present the company's results at 08:30 am CET at Hotel Continental, Stortingsgaten 24-26 in Oslo. A light breakfast will be served from 08:00. Selvaag Bolig's board of directors will be present and available for questions before and after the presentation. The presentation will

Hexagon Composites ASA: Results for the first quarter 2016

In the first quarter 2016 Hexagon Composites generated NOK 291.6 (401.6) million in operating income and made an operating profit before depreciation (EBITDA) of NOK 18.6 (52.9) million. Operating profit (EBIT) was NOK 3.2 (39.5) million and profit/loss before tax came to NOK -2.6 (53.3) million.Operating results in the first quarter were impacted positively by a 17% growth in revenues within the Low-Pressure Cylinders segment versus the same period last year. However weak sales volumes for Mobile Pipeline[TM] solutions has hampered overall profitability for the Group, within the High-

Finnair’s strategy review: Finnair to accelerate its growth

Finnair Plc                            Stock Exchange Release                           12 May 2016 at 9:05 am EET  As a part of its annual strategy review, Finnair's Board of Directors has defined the focus areas for 2016–2018 in order to achieve the company’s strategic objectives. These are: · Profitable growth – Finnair seeks to grow slightly faster than its previous targets and gain market share. · Customer experience – the Company is developing its customer service, aligned with its vision of a Nordic customer experience. · People experience – Finnair is focusing on human

Etrion Releases First Quarter 2016 Results

May 12, 2016, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, today released its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three months ended March 31, 2016. Operational Highlights · Development: Advanced the backlog of three projects in Japan for a total capacity of 76 megawatts (“MW”). Management expects to reach financial close for these backlog projects within the second half of 2016. The Company is advancing the development

Attendo first quarter report 2016:  Demand for own operations and high quality gave stable growth and margins

Attendo is showing stable growth and profits for the first quarter 2016, driven primarily by strong demand for own operations. The margin was in line with last year, despite unfavourable seasonal effect. Progress in Attendo’s quality work contributed to important contract wins during the quarter.Comments by Henrik Borelius, CEO:“The quarter shows stable growth and profits due to continued strong development in own operations. The margin was in line with the same quarter last year, despite the negative seasonal effect and the start-up of several new units. During the quarter Attendo won

SELUMETINIB GRANTED ORPHAN DRUG DESIGNATION IN US

SELUMETINIB granted Orphan Drug Designation in the US for ADJUVANT treatment of Differentiated thyroid cancer AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for the investigational MEK 1/2 inhibitor, selumetinib (AZD6244, ARRY-142886) for adjuvant treatment of patients with stage III or IV differentiated thyroid cancer (DTC). DTC is diagnosed in approximately 60,000 people in the US each year,1 and radioactive iodine (RAI) is recommended for those with known/suspected metastases at diagnosis and those at high risk of

D. Carnegie & Co included in two new indices – the Nasdaq Nordic VINX Benchmark Index and the EPRA European Index

D. Carnegie & Co (publ) - listed on Nasdaq Stockholm – has been included in the NASDAQ Nordic VINX Benchmark Index as of 1 June this year. The VINX Benchmark Index include the largest and most actively traded stocks on Nordic Exchanges. The weight in the index is based on the portion of the shares available for trading, ie. the so called free float.D. Carnegie Co's share has recently been included in the European Public Real Estate Association EPRA Index for European property companies. In order to be included in the EPRA indices a certain free float is required, as is a sufficient

Finnair Group interim report 1 January – 31 March 2016

Finnair Plc                            Stock Exchange Release                            12 May 2016 at 9:00 am EET  Comparable operating result improved by 13 million euros in the seasonally weakest quarter January–March 2016 · Revenue grew by 2.9% year-on-year to 536.4 million euros (521.3). · Comparable operating result was -15.3 million euros (-28.4). · Comparable EBITDAR was 36.4 million euros (19.2). · Net cash flow from operating activities stood at 10.4 million euros (13.0), and net cash flow from investing activities totalled -247.3 million euros (142.8). ·

Strong net collections from recent acquisitions

Highlights first quarter 2016- Net collections increased by 39% to EUR 7.9M (Q1 2015: EUR 5.7M)  - Cash EBITDA increased by 60% and amounted to EUR 6.6M (Q1 2015: EUR 4.2M)  - Profit for the period of EUR 0.1M (Q1 2015: profit of EUR 0.2M)  - Gross ERC at the end of March 2016 was EUR 70.9M (Q1 2015: EUR 63.8M)  - New portfolio acquired in the Czech Republic  - Secured additional debt financing in Q1 to fund the portfolio acquisition  - Pipeline of future transactions remains strong Significant events after the first quarter  - The recent Hungarian transaction closed

Interim report for Q1 2016

Bactiguard started the year by increasing sales of its own product portfolio and delivered approx. 87,600 units, which is more than half of the total volume in 2015. License revenues were lower due to the adjusted order from C.R Bard, but as of March the order situation is back at a stable level. Operating profit was negative, but mayor payments of accounts receivable contributed to a positive cash flow.First quarter (January-March 2016) · During the first quarter, a total of approx. 87,600 (4,650) BIP products were delivered, 100 % of which generated revenues. · Revenues amounted

CXENSE ASA ANNOUNCES FIRST QUARTER RESULTS - Q1 2016

OSLO, NORWAY – 12 MAY, 2016 - CXENSE ASA TODAY REPORTED FINANCIAL RESULTS FOR THE FIRST QUARTER, WHICH ENDED 31 MARCH, 2016. Highlights: · Q1 2016 revenues of USD 6.3 million, up 61% compared to Q1 2015 revenues of USD 3.9 million. · New Annualized Recurring Revenue (ARR) in Q1 2016 amounted to USD 1.6 million compared to USD 1.5 million in Q1 2015. · In Q1 2016 the company executed the final organizational re-focusing following the 2015 acquisitions. This led to one-off restructuring costs in the quarter, but also a significantly lower adjusted OPEX run-rate into Q2 2016. ·

Tiny hairs in the ear are essential to hearing

[PRESS INVITATION 12 May 2016] Many hearing problems are caused by damage to hair cells in the inner ear. James Hudspeth , Rockefeller University, researches how these cells capture sound and convert it to electrical signals, and how this knowledge can be used to prevent and repair hearing impairment. Professor Hudspeth will soon be coming to the Swedish medical university, Karolinska Institutet to talk more about his work.Reporters are welcome to attend his lecture “Making an Effort to Listen: Mechanical

Strong net collections from recent acquisitions

Highlights first quarter 2016- Net collections increased by 134% to SEK 68.6M (Q1 2015: SEK 29.3M)- Cash EBITDA increased by 105% and amounted to SEK 58.1M (Q1 2015: SEK 28.3M)- Profit for the period of SEK 0.0M (Q1 2015: profit of SEK 4.9M)- New portfolio acquired in the Czech Republic- Pipeline of future transactions remains strong Significant events after the first quarter- The recent Hungarian transaction closed at the end of April 2016, with the first cash flows from collections received in early MayComment by the CEOFollowing the largest transaction in DDM’s history

NCC to build rental units for Magnolia Bostad

NCC has been commissioned by Magnolia Bostad to build 454 rental units in central Uppsala, in the Senapsfabriken 2 property block. The order is valued at SEK 443 million.“This residential block will truly contribute to satisfying the Municipality’s need for housing in general and rental units in particular. Another aim is to have the building environmentally certified in accordance with Sweden Green Building Council Silver,” says Henrik Landelius, NCC Building Sweden. The classification takes into consideration such environmental factors as energy use, energy sources, indoor environment,

Read original

Resolutions adopted at the annual general meeting of Hansa Medical AB (publ)

N.B. the English version below is an office translation. In case of any discrepancy between the Swedish and the English version, the Swedish version shall prevail.The following resolutions, among others, were adopted by the annual general meeting of Hansa Medical AB (publ) held on 11 May 2016. DividendThe annual general meeting resolved that no dividend will be paid for the financial year 2015. Discharge from liabilityThe annual general meeting granted the directors and CEO discharge from liability in respect of the 2015 financial year. Board of directors and auditorThe

Nordea teams up with fintech startups again

There will be a new chance for startups to accelerate their ideas this autumn. The first Nordea Accelerator programme ran successfully during winter 2015-2016 where twelve selected startups developed their ideas in cooperation with Nordea. The next programme will run for 12 weeks starting September 2016 and is now open for applications.Now more fintech startups get a new chance to accelerate their business. Nordea’s programme is now open for applications from fintech startups all over the world. The first programme ran in Helsinki, and this time the startups can also choose to work on

Interim report Itiviti Group Holding AB January 1 – March 31, 2016

Strong progress with several wins in the quarter · Operating revenue for the period from January to March 2016 was SEK 174,858k (160,543), an increase of 9% compared to the same quarter of 2015. The Swedish krona has weakened against the euro and the US dollar, which has had a positive impact on revenue. Adjusted for foreign exchange effects, license revenue was up by SEK 5,737k (4%), most of which is attributable to increased sales of the products Tbricks by Itiviti, VeriFIX by Itiviti and Catalys by Itiviti. · Adjusted EBITDA was SEK 87,730k (67,033) and adjusted EBITDA-CAPEX

Elisa Corporation change of trading code

ELISA STOCK EXCHANGE RELEASE 12 MAY AT 9.00 AM Elisa's new trading code (stock symbol) in Nasdaq Helsinki is ELISA. Previously it was ELI1V. The new trading code is effective at the start of trading on 16 May 2016. Company identifiers: · Company name: Elisa Corporation · New trading code: ELISA · ISIN code: FI0009007884 ELISA CORPORATION Vesa Sahivirta                   IR Directortel. +358 10 262 3036 Distribution: Nasdaq Helsinki                Principal media                  www.elisa.com

RaySearch Laboratories AB (publ) Interim Report January 1 – March 31, 2016

“Revenues from RayStation® increased with 29 percent to SEK 80.8 M (62.8) and prospects are favorable for increased growth for the rest of the year. The development of RayCare® is progressing according to plan and we are planning a public demonstration of the system at the 2016 ASTRO Annual Meeting in Boston at the end of September,” says Johan Löf, President and CEO of RaySearch.THREE MONTHS (JANUARY-MARCH 2016) · Net sales SEK 95.4 M (87.7), of which RayStation SEK 80.8 M (62.7) · Profit after tax SEK 17.8 M (25.0), and earnings per share SEK 0.52 (0.73) · Operating profit SEK

NHS Supply Chain chooses Elekta to upgrade UK’s radiotherapy resources

CRAWLEY, UK, May 12, 2016 – The UK’s NHS Supply Chain (NHSSC) has signed an order to acquire linear accelerators (linacs) and software from Elekta (EKTA-B.ST) for a total value of GBP 21.5 million. The order was booked in the fourth quarter of Elekta’s fiscal year (2015-16).The order includes Elekta Synergy®  linacs with Agility™  multileaf collimators for high speed beam shaping. The Synergy linacs also include VMAT, which improves radiation therapy treatment speed and dose reduction to the patient. Andy Brown, Managing

Scandic’s interim report for the first quarter 2016 – Positive start to the year and good underlying demand

First quarter 2016 in summary · Results for the quarter were impacted by this year’s Easter holiday that fell entirely during the month of March. · LFL RevPAR grew 1.7% driven by greater occupancy. Total RevPAR decreased by 1.9% mainly as a result of exchange rate fluctuations. · Net sales LFL went up 2.3% due to continued good underlying demand.   · Net sales decreased by 2.6% to 2,594 MSEK (2,664), with mainly exchange rate fluctuations having a negative impact. · Adjusted EBITDA amounted to 40 MSEK (66) corresponding to a margin of 1.5% (2.5).The margin change is a

Three month report, January-March 2016

January-March 2016 compared to January-March 2015Highlights Revenue amounted to SEK 35.3 billion (34.1); adjusted for currency effects, revenue increased by 5 percent. Operating income amounted to SEK 1,969 M (832); adjusted for currency effects, operating income increased by 134 percent. Earnings per share increased by 193 percent to SEK 3.69 (1.26). Operating cash flow from operations amounted to SEK –3.4 billion (–2.5). Net investments amounted to SEK –1.8 billion (–0.5). Operating net financial assets totaled SEK 10.3 billion (5.9). Order bookings in Construction

There are no items matching the current filter
There are no more items matching the current filter
Back to top